RT @AshimaMakol: ð¥Continued, More Clinically Meaningful data in #SSc #ILD from #Nintedanib in >52 wk SENSCIS &
Tweet Content
🔥Continued, More Clinically Meaningful data in #SSc #ILD from #Nintedanib in >52 wk SENSCIS & SENSCIS-ON(open-label ext)#ACR21 Dr Distler
✨MMF likely to stay 1st line, then Nintedanib
❓Is it time for MMF + Antifibrotic upfront??
Await SLS-III;Data so far seems supportive https://t.co/JWXMlsJgmc
Show on Archive Page
On
Display in Search Results
On
PDQ
Off